Martin H. Huber Jr.

Insider Reports History

Entity
Individual
Location
C/O Tesaro, Inc., 1000 Winter Street, Suite 3300, Waltham, MA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin H. Huber Jr.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. President, CEO, Director Restricted Stock Unit 500K $980K $1.96 Sep 11, 2024 Direct
Syndax Pharmaceuticals Inc Director Common Stock 49K $895K $18.27 Feb 7, 2024 Direct
Mersana Therapeutics, Inc. President, CEO, Director Common Stock 116K $205K $1.76 Sep 12, 2024 Direct
Mersana Therapeutics, Inc. President, CEO, Director Restricted Stock Unit 44.3K $120K $2.71 Jan 15, 2024 Direct
Mersana Therapeutics, Inc. President, CEO, Director Stock Option (Right to Buy) 199K Jan 15, 2024 Direct
Xilio Therapeutics, Inc. PRESIDENT AND HEAD OF R&D Stock Option (right to buy) 137K Aug 16, 2023 Direct

Insider Reports Filed by Martin H. Huber Jr.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRSN Mersana Therapeutics, Inc. Sep 11, 2024 3 -$88.7K 4 Sep 13, 2024 President, CEO, Director
SNDX Syndax Pharmaceuticals Inc Feb 7, 2024 1 $0 4 Feb 9, 2024 Director
MRSN Mersana Therapeutics, Inc. Jan 15, 2024 2 $0 4 Jan 17, 2024 President, CEO, Director
MRSN Mersana Therapeutics, Inc. Oct 2, 2023 1 $0 4 Oct 4, 2023 President, CEO, Director
MRSN Mersana Therapeutics, Inc. Sep 11, 2023 2 $0 4 Sep 13, 2023 President, CEO, Director
XLO Xilio Therapeutics, Inc. Aug 16, 2023 1 $0 4 Aug 18, 2023 PRESIDENT AND HEAD OF R&D
MRSN Mersana Therapeutics, Inc. Jul 3, 2023 1 $0 4 Jul 6, 2023 Director
MRSN Mersana Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
MRSN Mersana Therapeutics, Inc. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $0 4 Feb 3, 2023 Director
XLO Xilio Therapeutics, Inc. Jan 1, 2023 1 $0 4 Jan 4, 2023 PRESIDENT AND HEAD OF R&D
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4/A Jun 23, 2022 PRESIDENT AND HEAD OF R&D
MRSN Mersana Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
XLO Xilio Therapeutics, Inc. Feb 22, 2022 1 $0 4 Feb 24, 2022 PRESIDENT OF R&D AND CMO
SNDX Syndax Pharmaceuticals Inc Feb 2, 2022 1 $0 4 Feb 3, 2022 Director
MRSN Mersana Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 1 $0 4 Oct 25, 2021 President of R&D and CMO
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 President of R&D and CMO
SNDX Syndax Pharmaceuticals Inc Sep 15, 2021 1 $678K 4 Sep 17, 2021 Director
SNDX Syndax Pharmaceuticals Inc Sep 15, 2021 0 $0 3 Sep 17, 2021 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 15, 2021 Director